1. Repositório Institucional da Universidade Federal de Sergipe - RI/UFS
  2. PRODUÇÃO CIENTÍFICA
  3. DFA - Departamento de Farmácia
  4. DFA - Artigos de periódicos
Use este identificador para citar ou linkar para este item: https://ri.ufs.br/jspui/handle/riufs/25227
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorDi Pietro, Giuliano-
dc.contributor.authorChornokur, Ganna-
dc.contributor.authorKumar, Nagi B.-
dc.contributor.authorDavis, Chemar-
dc.contributor.authorPark, Jong Y.-
dc.date.accessioned2026-07-06T19:17:35Z-
dc.date.available2026-07-06T19:17:35Z-
dc.date.issued2016-
dc.identifier.citationDI PIETRO, G. et al. Racial differences in the diagnosis and treatment of prostate cancer. International neurourology journal, Seoul, v. 20, n. 2, p. 112–119, 2016. Disponível em: https://www.einj.org/journal/view.php?doi=10.5213/inj.1632722.361. Acesso em: 17 jun. 2026.pt_BR
dc.identifier.issn2093-6931-
dc.identifier.urihttps://ri.ufs.br/jspui/handle/riufs/25227-
dc.languageengpt_BR
dc.publisherKorean Continence Societypt_BR
dc.relation.ispartofInternational neurourology journalpt_BR
dc.subjectProstatic neoplasmseng
dc.subjectHealthcare disparitieseng
dc.subjectAfrican americanseng
dc.titleRacial differences in the diagnosis and treatment of prostate cancerpt_BR
dc.typeArtigopt_BR
dc.identifier.licenseCreative Commons Atribuição-NãoComercial 4.0 Internacional (CC BY-NC 4.0)pt_BR
dc.description.resumoDisparities between African American and Caucasian men in prostate cancer (PCa) diagnosis and treatment in the United States have been well established, with significant racial disparities documented at all stages of PCa management, from differences in the type of treatment offered to progression-free survival or death. These disparities appear to be complex in nature, involving biological determinants as well as socioeconomic and cultural aspects. We present a review of the literature on racial disparities in the diagnosis of PCa, treatment, survival, and genetic susceptibility. Significant differences were found among African Americans and whites in the incidence and mortality rates; namely, African Americans are diagnosed with PCa at younger ages than whites and usually with more advanced stages of the disease, and also undergo prostate-specific antigen testing less frequently. However, the determinants of the high rate of incidence and aggressiveness of PCa in African Americans remain unresolved. This pattern can be attributed to socioeconomic status, detection occurring at advanced stages of the disease, biological aggressiveness, family history, and differences in genetic susceptibility. Another risk factor for PCa is obesity. We found many discrepancies regarding treatment, including a tendency for more African American patients to be in watchful waiting than whites. Many factors are responsible for the higher incidence and mortality rates in African Americans. Better screening, improved access to health insurance and clinics, and more homogeneous forms of treatment will contribute to the reduction of disparities between African Americans and white men in PCa incidence and mortality.pt_BR
dc.description.localSeoulpt_BR
dc.identifier.doihttps://doi.org/10.5213/inj.1632722.361-
Aparece nas coleções:DFA - Artigos de periódicos

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
RacialDifferencesDiagnosisProstateCancer.pdf296,13 kBAdobe PDFThumbnail
Visualizar/Abrir
Mostrar registro simples do item Visualizar estatísticas


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.